Table 5.
Effect of 20% VE on MAP, HR, MRAP, and RSNA after AVP V1 receptor blockade in rats receiving chronic infusions
| Vehicle-Infused Rats |
ANG II-Infused Rats |
|||
|---|---|---|---|---|
| Baseline | 20% VE | Baseline | 20% VE | |
| MAP, mmHg | 97 ± 10 | 104 ± 7 | 98 ± 5 | 104 ± 5 |
| HR, beats/min | 342 ± 18 | 317 ± 19 | 372 ± 32 | 350 ± 34 |
| MRAP, mmHg | −0.16 ± 0.8 | 0.76 ± 0.8 | −0.53 ± 0.6 | 0.53 ± 0.7 |
| ΔMRAP mmHg | 0.92 ± 0.14 | 1.0 ± 0.11 | ||
| RSNA % | 100 | 61.8 ± 3* | 100 | 91.5 ± 3† |
Values are means ± SE; n = 6 in both groups. AVP, arginine vasopressin.
P < 0.05 vs. baseline;
P < 0.001 vs. 20% VE in vehicle-infused rats.